Gelibter AJ - Search Results

1

Adjuvant chemotherapy in resected colon cancer: When, how and how long?

Gelibter AJ, Caponnetto S, Urbano F, Emiliani A, Scagnoli S, Sirgiovanni G, Napoli VM, Cortesi E. Gelibter AJ, et al. Surg Oncol. 2019 Sep;30:100-107. doi: 10.1016/j.suronc.2019.06.003. Epub 2019 Jul 2. Surg Oncol. 2019. PMID: 31500770 Review.

2

Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancer.

Di Cosimo S, Alimonti A, Ferretti G, Sperduti I, Carlini P, Papaldo P, Fabi A, Gelibter A, Ciccarese M, Giannarelli D, Mandalà M, Milella M, Ruggeri EM, Cognetti F. Di Cosimo S, et al. Ann Oncol. 2004 Jul;15(7):1065-71. doi: 10.1093/annonc/mdh266. Ann Oncol. 2004. PMID: 15205200 Free article.

3

Sequential chemotherapy in nonsmall-cell lung cancer: cisplatin and gemcitabine followed by docetaxel.

Ceribelli A, Pino MS, Gelibter AJ, Milella M, Cecere FL, Caterino M, Facciolo F, Mirri A, Cognetti F. Ceribelli A, et al. Among authors: gelibter aj. Cancer. 2007 Feb 15;109(4):727-31. doi: 10.1002/cncr.22480. Cancer. 2007. PMID: 17238182 Free article. Clinical Trial.

4

A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer.

Gelibter AJ, Gamucci T, Pollera CF, Di Costanzo F, Nuzzo C, Gabriele A, Signorelli C, Gasperoni S, Ferraresi V, Giannarelli D, Cognetti F, Zeuli M. Gelibter AJ, et al. Curr Med Res Opin. 2007 Sep;23(9):2117-23. doi: 10.1185/030079907X226113. Curr Med Res Opin. 2007. PMID: 17651538 Clinical Trial.

5

Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers.

Pino MS, Milella M, Gelibter A, Sperduti I, De Marco S, Nuzzo C, Bria E, Carpanese L, Ruggeri EM, Carlini P, Cognetti F. Pino MS, et al. Oncology. 2009;76(4):254-61. doi: 10.1159/000205388. Epub 2009 Feb 26. Oncology. 2009. PMID: 19246950 Clinical Trial.

6

Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab.

Caponnetto S, Iannantuono GM, Barchiesi G, Magri V, Gelibter A, Cortesi E. Caponnetto S, et al. Oncology. 2017;93(1):62-66. doi: 10.1159/000464328. Epub 2017 Apr 14. Oncology. 2017. PMID: 28407622

7

Use of Adjuvant Chemotherapy After Surgery in Patients With Colon Cancer.

Gelibter AJ, Mosillo C, Sirgiovanni G. Gelibter AJ, et al. JAMA Surg. 2017 Sep 1;152(9):895. doi: 10.1001/jamasurg.2017.1617. JAMA Surg. 2017. PMID: 28614583 No abstract available.

8

Burned-Out Testicular Cancer: Really a Different History?

Mosillo C, Scagnoli S, Pomati G, Caponnetto S, Mancini ML, Bezzi M, Cortesi E, Gelibter A. Mosillo C, et al. Case Rep Oncol. 2017 Sep 20;10(3):846-850. doi: 10.1159/000480493. eCollection 2017 Sep-Dec. Case Rep Oncol. 2017. PMID: 29071000 Free PMC article.

9

PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system?.

Raimondi C, Carpino G, Nicolazzo C, Gradilone A, Gianni W, Gelibter A, Gaudio E, Cortesi E, Gazzaniga P. Raimondi C, et al. Oncoimmunology. 2017 Apr 20;6(12):e1315488. doi: 10.1080/2162402X.2017.1315488. eCollection 2017. Oncoimmunology. 2017. PMID: 29209560 Free PMC article.

10

TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway.

Zizzari IG, Napoletano C, Botticelli A, Caponnetto S, Calabrò F, Gelibter A, Rughetti A, Ruscito I, Rahimi H, Rossi E, Schinzari G, Marchetti P, Nuti M. Zizzari IG, et al. Cancer Immunol Res. 2018 Jun;6(6):711-722. doi: 10.1158/2326-6066.CIR-17-0594. Epub 2018 Apr 26. Cancer Immunol Res. 2018. PMID: 29700053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters